MONJUVI Trademark

Trademark Overview


On Wednesday, November 6, 2019, a trademark application was filed for MONJUVI with the United States Patent and Trademark Office. The USPTO has given the MONJUVI trademark a serial number of 88682860. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by MorphoSys AG. The MONJUVI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; cl...

Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development ser...
monjuvi

General Information


Serial Number88682860
Word MarkMONJUVI
Filing DateWednesday, November 6, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6173000
Registration DateTuesday, October 13, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Description of MarkThe mark consists of the term "MONJUVI" having a spherical shape appearing above the "i".
Goods and ServicesPharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINCYTE HOLDINGS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19803

Party NameMorphoSys AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Trademark Events


Event DateEvent Description
Sunday, December 15, 2019ASSIGNED TO EXAMINER
Wednesday, December 18, 2019NON-FINAL ACTION WRITTEN
Saturday, November 9, 2019NEW APPLICATION ENTERED
Thursday, November 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 15, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 18, 2019NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2020ASSIGNED TO LIE
Monday, June 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, April 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, June 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP